ENLIGHT-NGS

RNA-based Drug Matching Analysis Nomination

ENLIGHT-NGS is an extensively validated treatment matching test driven by deep transcriptomic analysis

Based on sequencing derived from standard FFPE (Formalin Fixed, Paraffin Embedded) pathology samples, ENLIGHT-NGS delivers an actionable report helping physicians to make informed treatment decisions. ENLIGHT-NGS screens dozens of treatment options, assigning each an ENLIGHT Matching Score, and presenting the results in an intuitive, easy-to-understand report, delivering concrete actionable insights to the oncologist. ENLIGHT-matched drugs are categorized according to the level of evidence supporting their match, aiding healthcare professionals to find the best treatment for each patient. ENLIGHT-NGS tests are commercially available in several countries, and expanding to additional ones. Contact us to learn more.

ENLIGHT-DP

Treatment Matching Analysis Directly from H&E Slides

ENLIGHT-DP is a ground-breaking solution for response insights directly from H&E slides

DeepPT, Pangea's novel digital pathology (DP) deep learning platform, combined with the power of ENLIGHT to screen dozens of treatment options, generates results and insights directly from standard H&E-stained pathology slides. ENLIGHT-DP computes ENLIGHT Matching Scores for dozens of drugs, delivering actionable insights about patients’ treatment options without the need to wait for NGS results. ENLIGHT-DP tests will become commercially available in 2025.
mail

We are always open for collaboration

contact us for collaboration opportunities arrow